[ Price : $8.95]
FDA clears a Neuronetics 510(k) for a new indication for its NeuroStar Advanced Therapy for Mental Health device, a transcranial m...[ Price : $8.95]
FDA warns Spains Bioiberica about CGMP deviations in its manufacturing of active pharmaceutical ingredients.[ Price : $8.95]
FDA warns Imprimis Rx that professional promotional materials for a compounded ophthalmic drug make false and misleading statement...[ Price : $8.95]
FDA lifts a clinical hold against Viking Therapeutics VK0214 in patients with X-linked adrenoleukodystrophy.[ Price : $8.95]
Merck halts a Phase 3 LYNK-003 trial investigating Lynparza (olaparib) with or without bevacizumab for treating patients with unre...[ Price : $8.95]
CDER director Patrizia Cavazzoni selects associate director for controlled substances Marta Sokolowska to serve as deputy Center d...[ Price : $8.95]
The Washington Legal Foundation says an OIG advisory opinion puts life sciences companies on notice to be cautious in the way they...[ Price : $8.95]
California pain doctor Gerald Sacks agrees to pay $271,259.12 to resolve anti-kickback allegations involving drugs manufactured by...